Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Prostatic Neoplasms 31Glioblastoma 28Breast Neoplasms 20Lung Neoplasms 17Carcinoma, Non-Small-Cell Lung 17Oropharyngeal Neoplasms 14Squamous Cell Carcinoma of Head and Neck 11Sarcoma 10Glioma 10Esophageal Neoplasms 10Brain Neoplasms 10Urinary Bladder Neoplasms 9Astrocytoma 9Gliosarcoma 8Triple Negative Breast Neoplasms 7Neoplasm Metastasis 7Mouth Neoplasms 7Uterine Cervical Neoplasms 6Rectal Neoplasms 6Melanoma 6Head and Neck Neoplasms 6Carcinoma, Hepatocellular 6Carcinoma 6Adenocarcinoma Of Esophagus 6Stomach Neoplasms 5Pancreatic Neoplasms 5Neoplasms 5Laryngeal Neoplasms 5Esophageal Squamous Cell Carcinoma 5Carcinoma, Squamous Cell 5

Interventions

Radiotherapy 1Radiation 1Platinum 1Cisplatin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Locally Advanced Cervical Squamous Cell Carcinoma, Not Otherwise Specified × Radiation × 1 year × Clear all
NCT04580771 2026-04-15

A Vaccine (PDS0101) and Chemoradiation for the Treatment of Stage IB3-IVA Cervical Cancer, the IMMUNOCERV Trial

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
22 enrolled
Gynecologic

Locally Advanced Cervical Squamous Cell Carcinoma, Not Otherwise Specified

Data powered by HemOnc (CC BY 4.0) Colophon âš¡